NCT00491634View on ClinicalTrials.gov

Treosulfan-based Conditioning for Transplantation in AML/MDS

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Interventions
DRUG

treosulfan

12 g/m2 x 3 days

DRUG

Treosulfan

12 g/m2 x 3

Trial Locations (1)

Unknown

Chaim Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Dr. Avichai Shimoni MD

OTHER_GOV

NCT00491634 - Treosulfan-based Conditioning for Transplantation in AML/MDS | Biotech Hunter | Biotech Hunter